论文部分内容阅读
机体免疫系统在癌瘤发生、发展上起着重要作用。原发性和医疗性免疫缺陷,可导致细胞瘤化骤增。这些人的癌瘤发生率比一般人群约高100倍。而当前治疗癌瘤的常用方法,包括手术根治,放疗,化疗均可损害宿主的抗癌力而对机体产生免疫抑制作用。为了减少癌瘤患者在上述治疗中对机体的免疫抑制,尽可能地增强其免疫反应,我们于78年对10例鼻咽癌患者在使用化疗药物前,选用中草药治疗。所用的中草药是:核葵注射液(北京第四药厂生产,含核桃树枝1g/2ml、龙葵0.1g/2ml)和全国鼻咽癌
The immune system plays an important role in the occurrence and development of cancer. Primary and medical immunodeficiency can lead to a sudden increase in cell neoplasia. The incidence of cancer in these people is about 100 times higher than that of the general population. The current common methods for the treatment of cancer, including radical surgery, radiotherapy, and chemotherapy, can damage the host’s anti-cancer power and produce immunosuppressive effects on the body. In order to reduce the immunosuppression of the cancer patients in the above treatment and enhance their immune response as much as possible, we used Chinese herbal medicine to treat 10 patients with nasopharyngeal carcinoma before using chemotherapy drugs in 78 years. The Chinese herbs used are: nuclear sunflower injection (produced by Beijing No. 4 Pharmaceutical Factory, containing 1g/2ml of walnut branches, 0.1g/2ml of Solanum nigrum) and national nasopharyngeal carcinoma